CHESHIRE, United Kingdom, April 28, 2025 (GLOBE NEWSWIRE) -- BlackfinBio Ltd, a clinical stage gene therapy company focused on the development of treatments for rare neurological diseases, announces ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback